Imbalance between IL-17A-producing cells and regulatory T cells during ischemic stroke

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Hu, Yuehua ^a   Zheng, Yanhua ^b   Wu, Ya ^a   Ni, Bing ^a   Shi, Shugui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 306 HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 23; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; MALE; MIDDLE AGED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; BLOOD; CEREBROVASCULAR ACCIDENT; GENETICS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL;

ADULT; AGED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; STROKE; T-LYMPHOCYTES, REGULATORY;

EID: 84903640356     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/813045     Document Type: Article

References (39)

1. Deb P., Sharma S., Hassan K. M., Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010 17 3 197 218 2-s2.0-77952675659 10.1016/j.pathophys.2009.12.001
2. Moskowitz M. A., Lo E. H., Iadecola C., The science of stroke: mechanisms in search of treatments. Neuron 2010 67 2 181 198 2-s2.0-77955487488 10.1016/j.neuron.2010.07.002
3. Iadecola C., Anrather J., The immunology of stroke: from mechanisms to translation. Nature Medicine 2011 17 7 796 808 2-s2.0-79960141471 10.1038/nm.2399
4. Hurn P. D., Subramanian S., Parker S. M., Afentoulis M. E., Kaler L. J., Vandenbark A. A., Offner H., T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. Journal of Cerebral Blood Flow and Metabolism 2007 27 11 1798 1805 2-s2.0-35448947910 10.1038/sj.jcbfm.9600482 (Pubitemid 47624547)
5. Kleinschnitz C., Schwab N., Kraft P., Hagedorn I., Dreykluft A., Schwarz T., Austinat M., Nieswandt B., Wiendl H., Stoll G., Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010 115 18 3835 3842 2-s2.0-77952557777 10.1182/blood-2009-10-249078
6. Bluestone J. A., MacKay C. R., O'Shea J. J., Stockinger B., The functional plasticity of T cell subsets. Nature Reviews Immunology 2009 9 11 811 816 2-s2.0-70350568800 10.1038/nri2654
7. Kirkham B. W., Kavanaugh A., Reich K., Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 2014 141 2 133 142
8. Kostic M., Dzopalic T., Zivanovic S., Zivkovic N., Cvetanovic A., Stojanovic I., Vojinovic S., Marjanovic G., Savic V., Colic M., IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis. Scandinavian Journal of Immunology 2014 79 3 181 186
9. Brkic Z., Corneth O. B., van Helden-Meeuwsen C. G., Dolhain R. J., Maria N. I., Paulissen S. M., Davelaar N., van Hamburg J. P., van Daele P. L., Dalm V. A., van Hagen P. M., Hazes J. M., Versnel M. A., Lubberts E., T helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus? Arthritis Research and Therapy 2014 16 2, article R62
10. Bishu S., Su E. W., Wilkerson E. R., Reckley K. A., Jones D. M., McGeachy M. J., Gaffen S. L., Levesque M. C., Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses. Arthritis Research and Therapy 2014 16 1, article R50
11. Roark C. L., Simonian P. L., Fontenot A. P., Born W. K., O'Brien R. L., Gammadelta T cells: an important source of IL-17. Current Opinion in Immunology 2008 20 3 353 357
12. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D. J., Iwakura Y., Yoshimura A., Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury. Nature Medicine 2009 15 8 946 950 2-s2.0-68349160698 10.1038/nm.1999
13. Noack M., Miossec P., Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmunity Reviews 2014 13 6 668 677
14. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., Veltkamp R., Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 2009 15 2 192 199 2-s2.0-59649123881 10.1038/nm.1927
15. Schroeter M., Jander S., Witte O. W., Stoll G., Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. Journal of Neuroimmunology 1994 55 2 195 203 2-s2.0-0028597088 10.1016/0165-5728(94)90010-8
16. Arya M., Shergill I. S., Williamson M., Gommersall L., Arya N., Patel H. R. H., Basic principles of real-time quantitative PCR. Expert Review of Molecular Diagnostics 2005 5 2 209 219 2-s2.0-15444370610 10.1586/14737159.5.2. 209 (Pubitemid 40396226)
17. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C., Siler D. A., Arumugam T. V., Orthey E., Gerloff C., Tolosa E., Magnus T., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009 40 5 1849 1857 2-s2.0-65549130913 10.1161/STROKEAHA.108.534503
18. Shichita T., Ago T., Kamouchi M., Kitazono T., Yoshimura A., Ooboshi H., Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. Journal of Neurochemistry 2012 123 supplement 2 29 38 2-s2.0-84867508424 10.1111/j.1471-4159.2012.07941.x
19. Gelderblom M., Leypoldt F., Lewerenz J., Birkenmayer G., Orozco D., Ludewig P., Thundyil J., Arumugam T. V., Gerloff C., Tolosa E., Maher P., Magnus T., The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. Journal of Cerebral Blood Flow and Metabolism 2012 32 5 835 843 2-s2.0-84860437011 10.1038/jcbfm.2011.189
20. Swardfager W., Winer D. A., Herrmann N., Winer S., Lanctôt K. L., Interleukin-17 in post-stroke neurodegeneration. Neuroscience and Biobehavioral Reviews 2013 37 3 436 447 2-s2.0-84874510318 10.1016/j.neubiorev.2013.01.021
21. Yan J., Greer J. M., Etherington K., Cadigan G. P., Cavanagh H., Henderson R. D., O'Sullivan J. D., Pandian J. D., Read S. J., McCombe P. A., Immune activation in the peripheral blood of patients with acute ischemic stroke. Journal of Neuroimmunology 2009 206 1-2 112 117 2-s2.0-58149229352 10.1016/j.jneuroim.2008.11.001
22. Kostulas N., Pelidou S. H., Kivisäkk P., Kostulas V., Link H., Increased IL-1 β IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999 30 10 2174 2179 2-s2.0-0032589394 (Pubitemid 29473266)
23. Hildebrandt F., Otto E., Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nature Reviews Genetics 2005 6 12 928 940 2-s2.0-28844460656 10.1038/nrg1727 (Pubitemid 41778699)
24. Wan Y. Y., Multi-tasking of helper T cells. Immunology 2010 130 2 166 171 2-s2.0-77952027489 10.1111/j.1365-2567.2010.03289.x
25. Sutton C. E., Lalor S. J., Sweeney C. M., Brereton C. F., Lavelle E. C., Mills K. H. G., Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009 31 2 331 341 2-s2.0-68649088121 10.1016/j.immuni.2009.08.001
26. Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P., Steinbach K., Orthey E., Arumugam T. V., Leypoldt F., Simova O., Thom V., Friese M. A., Prinz I., Hölscher C., Glatzel M., Korn T., Gerloff C., Tolosa E., Magnus T., Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012 120 18 3793 3802 2-s2.0-84868602402 10.1182/blood-2012-02-412726
27. Siniscalchi A., Gallelli L., Malferrari G., Pirritano D., Serra R., Santangelo E., de Sarro G., Cerebral stroke injury: the role of cytokines and brain inflammation. The Journal of Basic and Clinical Physiology and Pharmacology 2014 25 2 131 137
28. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007 317 5835 256 260 2-s2.0-34447503805 10.1126/science.1145697 (Pubitemid 47076203)
29. Ziegler S. F., FOXP3: of mice and men. Annual Review of Immunology 2006 24 209 226 2-s2.0-33646168597 10.1146/annurev.immunol.24.021605.090547
30. Planas A. M., Chamorro A., Regulatory T cells protect the brain after stroke. Nature Medicine 2009 15 2 138 139 2-s2.0-59649128971 10.1038/nm0209-138
31. + regulatory T cells promotes hypercholesterolemia and atherosclerosis. The Journal of Clinical Investigation 2013 123 3 1323 1334 2-s2.0-84874597449 10.1172/JCI63891
32. + regulatory T-cells in cerebral ischemic stroke. Metabolic Brain Disease 2011 26 1 87 90 2-s2.0-79955083477 10.1007/s11011-010- 9226-6
33. Yan J., Read S. J., Henderson R. D., Hull R., O'Sullivan J. D., McCombe P. A., Greer J. M., Frequency and function of regulatory T cells after ischaemic stroke in humans. Journal of Neuroimmunology 2012 243 1-2 89 94 2-s2.0-84856955229 10.1016/j.jneuroim.2011.12.019
34. + regulatory T cells in patients with acute coronary syndromes. European Heart Journal 2006 27 21 2530 2537 2-s2.0-33750314730 10.1093/eurheartj/ehl222 (Pubitemid 44627295)
35. + regulatory T cells in experimental atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 893 900 2-s2.0-34247190299 10.1161/01.ATV.0000259365.31469.89 (Pubitemid 46606722)
36. Flynn R. W. V., MacDonald T. M., Murray G. D., MacWalter R. S., Doney A. S. F., Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort. Cerebrovascular Diseases 2012 33 2 190 197 2-s2.0-84855878750 10.1159/000331933
37. Youssef S., Stüve O., Patarroyo J. O., Ruiz P. J., Radosevich J. L., Mi Hur E., Bravo M., Mitchell D. J., Sobel R. A., Stelnman L., Zamvil S. S., The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002 420 6911 78 84 2-s2.0-0037038402 10.1038/nature01158 (Pubitemid 35291443)
38. Ng H. P., Burris R. L., Nagarajan S., Attenuated atherosclerotic lesions in apoE-Fc γ -chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells. Journal of Immunology 2011 187 11 6082 6093 2-s2.0-82755189236 10.4049/jimmunol.1004133
39. Maganto-García E., Tarrio M. L., Grabie N., Bu D., Lichtman A. H., Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 2011 124 2 185 195 2-s2.0-79960410419 10.1161/CIRCULATIONAHA.110.006411